sMtCK Monoclonal Antibody

Mitochondrial creatine kinase (MtCK) is responsible for the transfer of high energy phosphate from mitochondria to the cytosolic carrier, creatine. It belongs to the creatine kinase isoenzyme family. It exists as two isoenzymes, sarcomeric MtCK and ubiquitous MtCK, encoded by separate genes. Mitochondrial creatine kinase occurs in two different oligomeric forms: dimers and octamers, in contrast to the exclusively dimeric cytosolic creatine kinase isoenzymes. Sarcomeric mitochondrial creatine kinase has 80% homology with the coding exons of ubiquitous mitochondrial creatine kinase. This gene contains sequences homologous to several motifs that are shared among some nuclear genes encoding mitochondrial proteins and thus may be essential for the coordinated activation of these genes during mitochondrial biogenesis. 

Introducing the SMTCK Monoclonal Antibody, a cutting-edge biotechnological product meticulously developed to revolutionize the field of immunology. This highly advanced monoclonal antibody is designed to specifically target and bind to a wide range of antigens, enabling precise and efficient detection and analysis of various biological substances.

Crafted with utmost precision and utilizing state-of-the-art techniques, the SMTCK Monoclonal Antibody boasts exceptional specificity and sensitivity, ensuring accurate and reliable results in diverse applications. Its robust binding affinity allows for the identification and quantification of target antigens with unparalleled precision, facilitating groundbreaking advancements in research, diagnostics, and therapeutic development.

The SMTCK Monoclonal Antibody's exceptional performance is further enhanced by its exceptional stability and consistency, guaranteeing consistent and reproducible outcomes across experiments and assays. Its superior quality and reliability make it an indispensable tool for scientists, clinicians, and researchers alike, empowering them to unravel the complexities of the immune system and unlock new avenues of scientific discovery.

With its user-friendly formulation and straightforward application protocols, the SMTCK Monoclonal Antibody ensures ease of use and seamless integration into existing laboratory workflows. Its versatility enables its utilization across a wide range of experimental platforms, including immunohistochemistry, flow cytometry, Western blotting, and ELISA, among others.

Embrace the future of immunological research and diagnostics with the SMTCK Monoclonal Antibody, a pinnacle of scientific innovation and excellence. Elevate your scientific endeavors and unlock the potential of immunology with this remarkable product, poised to redefine the boundaries of scientific exploration and contribute to the advancement of human health and well-being.